Regulation & Compliance

A federal jury exonerated hedge fund Armistice Capital of all fraud claims related to Vaxart's COVID-era stock surge, a major trial loss for investors.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

Backed by SEI's billions, Stratos's acquisition spree isn't just about growth; it's pioneering a new partnership model for independent financial advisors.

With a new VP and expanded partnerships, KIBO Commerce is capitalizing on the region's shift away from legacy tech to its flexible, composable solutions.

Israel's top bank reports NIS 2.1B profit, showcasing economic resilience amid conflict and regulatory pressure while rewarding shareholders with dividends.

Amid industry-wide price pressure, MariMed reports revenue growth and improved profitability, bolstered by savvy debt restructuring and brand expansion.

The insurtech's capital-light model shines with soaring revenue and adjusted profits, proving the power of its Risk Exchange despite a reported net loss.

Online firearms retailer GrabAGun reports strong sales growth, but strategic spending on new ventures and infrastructure leads to a Q1 net loss.

A new partnership integrates Factor's ready-to-eat meals with Berry Street's insured dietitian network, using your meal data to offer personalized advice.

A major pickleball patent dispute ends as JOOLA and Paddletek settle, but the legal battle for nine other brands is just beginning. What does this mean?

The eco-retailer's new report details massive plastic cuts and a 10,000-chemical ban, raising the stakes for the industry and its own financial future.

Haven Capital and Altaline launch Ascend Safety Collective, a new platform using a 'roll-up' strategy and employee ownership to consolidate the fragmented market.

Techstars' exclusive partnership with Xendoo and Xero signals a new era of strict financial discipline for startups, driven by AI and investor demands.

As EHS teams face a talent crisis and rising regulations, a new AI platform promises to shift compliance from reactive data entry to proactive risk management.

A new report reveals a startling gap: while middle market firms embrace AI, their security isn't keeping up, creating a major risk despite high confidence.

A new study reveals a major trust gap in AI, showing top models align with professional experts only 70% of the time. Is AI ready for the real world?

Amid federal policy changes threatening to cut off millions, Yale New Haven Health partners with Escher Health to use AI for enrolling vulnerable patients.

ICON plc opens a state-of-the-art San Antonio research unit, aiming to accelerate drug development and improve the patient trial experience.

A new campaign is challenging perceptions of Alzheimer's, but it's fueled by more than stories. It's a nexus of new drugs, blood tests, and patient advocacy.